The talk will take place on September 24 at 13:25.
Pepticom is pleased to announce that Pierre Riviere, Ph.D., has joined the company’s Scientific Advisory Board to advise Pepticom on its peptide therapeutics strategy, programs and business.
Dr. Riviere has over 25 years of biopharmaceutical industry experience with R&D leadership roles in target and drug discovery, nonclinical and early-stage clinical development. He is a recognized expert in peptide therapeutics with both established peptide modalities and emerging novel peptide technologies. Dr. Riviere is Founder and CEO of Peptide Logic, a San Diego-based biotech […]
For more information: email@example.com.
We will be happy to see you there! For more information, please contact: firstname.lastname@example.org.
For more information, please contact: email@example.com
Dr. Amit Michaeli, Pepticom CTO, will discuss principles from our algorithm: From Finance to AI Drug Discovery. For more information: firstname.lastname@example.org.
Dr. Immanuel Lerner, Pepticom’s CEO, is an invited speaker at the BASEL LIFE Peptide Therapeutic Forum
The conference will take place on September 13-14, 2018. We will be happy to meet during the conference. For more information: email@example.com.
The risk and return heuristic describes a novel new approach for Peptide discovery. ( https://www.researchtrends.net/tia/title_issue.aspid=26&in=0&vn=18&type=3″
Pepticom’s BDO, Dr. Maayan Elias Robicsek, will attend the BIO-EUROPE SPRING 2018 partnering conference.
The conference will take place on March 12-14 in Amsterdam, The Netherlands. For more information:firstname.lastname@example.org.